Home Videos St. Jude Develops First ‘Living Drug’ for Childhood Leukemia

St. Jude Develops First ‘Living Drug’ for Childhood Leukemia


The FDA approved the first treatment to use a patient’s own cells on a form of childhood leukemia, opening a new era in cancer care, thanks to the work done at St. Jude Children’s Research Hospital.

Researchers say the first “living drug” of its type to hit the market could alter how doctors treat aggressive childhood cancer. Though costly, the new gene therapy price is less than bone marrow or stem cell transplants and poses fewer risks.

And, the hope is that similar techniques can treat aggressive brain tumors, bone tumors and muscle tumors, but more research is still needed.

Kym Clark/Kendall Downing, WMC Action News 5

You may also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

The Memphis 100